(Health Korea News / Changyong Lee) ‘Pharmaceutical 24 Hours’ is a corner that shows brief news related to pharmaceutical and biotechnology at a glance that is easy to miss. It may seem like trivial news, but it could be valuable information to someone, so we summarize the facts and present them in an easy-to-understand manner.
◆ Dongseong Pharmaceutical and Mom’s Milli, signed MOU to improve postpartum health, etc.
On the 14th, Dongseong Pharmaceutical signed a business agreement (MOU) to improve postpartum health with Mom’s Milli, a high-end postpartum care center operator.
The signing ceremony was held at the Noble 5 Postpartum Care Center operated by Mom’s Mill, and Dongsung Pharmaceutical’s Postpartum Care Center General Manager Kwon Oh-yoon and Mom’s Mill General Manager Seung Kang-soo attended. This MOU was concluded to establish a postpartum care system for mothers through products developed by Dongseong Pharmaceutical.
Dongsung Pharmaceutical started its probiotics business for newborn intestinal health in 2013 and has recently been introducing lactic acid bacteria and vitamin D+K2 products for the health of the whole family through the health functional food brand ‘DS-BIO’. In addition, we are focusing on product development and research for the health of mothers and their families through ‘NABODA’, a body care brand exclusively for mothers, and ‘WOW’, a premium organic sanitary napkin brand.
Dongseong Pharmaceutical is planning to distribute ‘Dangbaksa Rice’, a functional rice that prevents blood sugar levels from rising, and is expected to help manage gestational diabetes caused by pregnancy and improve the dietary health of mothers.
◆ GC Green Cross Wellbeing confirms the efficacy of placental injection ‘Rynek Injection’ in regulating immunity and improving skin barrier in animal models
GC Green Cross Wellbeing announced on the 15th that the human placenta hydrolyzate ‘Rynek Injuries’ has been confirmed to have immune regulation and skin barrier improvement effects as well as anti-inflammatory and analgesic effects in animal models.
‘Rynek Injection’ is made from human placenta hydrolyzate extracted from the human placenta, and is an injection approved for the purpose of improving liver function in patients with chronic liver disease.
In this anti-atopy study, hypersensitivity was artificially induced in mice and Rynek injection was administered to measure the effect of improving atopy. When hypersensitivity was induced, severe erythema, dryness, and scarring were observed in skin lesions, and IgE, an allergy-causing factor in the blood, increased and the skin barrier deteriorated. However, in the group administered Rynek injection, skin lesions were improved, blood IgE decreased by 27%, and Filaggrin, a factor that protects skin moisture and skin barrier, increased by 31%. The research paper was selected as the ‘KMB (Korean Society for Microbiology and Biotechnology) Excellent Paper’ in December last year, proving the excellence of the research.
According to a pain relief study published in the SCI(E) level international journal Pharmaceuticals, Rynek Injection reduces the expression of inflammatory cytokines (TNF-α, IL-6, IL-1β), which are known to be the main causes of inflammatory pain, by up to 75%. suppressed until The expression of GFAP and iba-1, markers of spinal cord inflammation, was also suppressed by 39% and 43%, respectively, showing excellent effectiveness in preventing nerve damage.
◆ HIRA-Hana Bank joint ESG conducts kimchi sharing activities
On the 14th, the Health Insurance Review and Assessment Service conducted a kimchi sharing activity as a joint project with Hana Bank and ESG.
This sharing activity was carried out by purchasing all the ingredients needed for kimchi, such as cabbage and red pepper powder, grown directly by residents of Samsong Village, Sillim-myeon, Wonju, who signed a 1 Company 1 Village sisterhood relationship with the Review and Assessment Service, and was prepared to provide winter support to neighbors who need a helping hand. Done.
In order to strengthen mutual ties and promote regional development, HIRA signed a ‘one institution, one village sisterhood relationship’ with Samsong Village in 2011, and has continued kimchi sharing activities for 13 consecutive years since 2012.
On this day, about 20 HIRA executives and staff volunteers and residents of Samsong Village participated in the event to make kimchi (1,000 kg) to be distributed to neighbors in need. The kimchi made by hand was evenly distributed to local residents, including the elderly living alone, the disabled, and children in welfare facilities, through the Wonju City Social Welfare Council, Wonju Independent Living Center for the Disabled, and Gangwon Children’s Welfare Center.
◆ National Health Insurance Corporation, obtained the highest grade in the 2024 National Core-Based Disaster Management Evaluation
The National Health Insurance Corporation (NHIC) announced on the 15th that it achieved an A grade for two consecutive years as a result of the ‘2024 National Core-Based Disaster Management Evaluation’.
The national core infrastructure disaster management evaluation hosted by the Ministry of Public Administration and Security covers 144 organizations in 11 fields designated as national core infrastructure in accordance with the Framework Act on Disaster and Safety Management, including setting protection goals and protection targets, risk assessment, key risk management, and disaster management. evaluate.
The National Health Insurance Corporation’s National Health Insurance Information System has been designated as a national core infrastructure in the information and communication field since 2013. The Corporation has achieved an A grade in the disaster management evaluation for two consecutive years in recognition of its consistent efforts to maintain core health insurance functions, such as providing uninterrupted health insurance services to the public by strengthening the management system of designated national core infrastructure facilities in preparation for disaster situations. Obtained the highest grade.
◆ HIRA to hold the 2024 Healthcare Big Data Future Forum
On November 26, the Health Insurance Review and Assessment Service (HIRA) will hold the ‘2024 Healthcare Big Data Future Forum’ under the theme ‘Direction of utilizing healthcare big data in the era of artificial intelligence’ at the aT Center Segero Room located in Seocho-gu, Seoul. is held.
This forum consists of a total of two sessions, and the keynote lecture will be given by Professor Cha Sang-gyun of Seoul National University on big data-based innovation, artificial intelligence, and future healthcare.
In the first session, Professor Lee Jin-hyung of Stanford University gave a presentation on the trends and prospects of AI in the health and medical field, and the Director of Policy Research Institute of the Review and Assessment Service took the chair, including Professor Myeong-ae Jeong of Eulji University, Jeong-pil Choi, advisor of Coreline Soft, and Jong-ho Heo, National Assembly Futures Institute Quality of Life Director. A discussion between data center directors is planned to take place.
In the second session, the topic was the use case of unstructured data in the medical field, ▲ Guidelines for pseudonymization of unstructured data (Secretary Moon-ho Joo, Personal Information Protection Committee), ▲ Case study on clinical application of artificial intelligence products based on Lung CT images (Team leader Jong-hoon Jeong, Vuno) Research and Development Division), ▲Introduction of HIRA AI-based medical image interpretation model (Team Leader Nam-won Jeong, HIRA), ▲Development of use of medical image verification lab A case study (Team Leader Shin Seung-woo, Crescom) will be presented.
◆ Yuhan Corporation holds a career program for youth who will lead the future pharmaceutical and bio industry
Yuhan Corporation announced on the 14th that it held the ‘Willow Science Career Camp’, a career experience program for youth in the pharmaceutical and bio industry.
Willow Science Career Camp is a career experience program in the pharmaceutical bio industry that Yuhan Corporation has been conducting for youth since 2019. In 2023, its related achievements were recognized by the Ministry of Education and it was selected as the ‘Education Donation Career Experience Certification System’, establishing itself as a representative career experience program in the pharmaceutical and bio industry.
This year, it is being carried out in three regions near the business, including Seoul, Yongin, and Cheongju, in conjunction with youth career experience specialized organizations and local schools. Last July, it was held at the headquarters for about 120 high school students from 3 high schools in Dongjak-gu, and in November, it was conducted with 62 high school students from 16 schools in Yongin City in cooperation with Yongin Future Education Center, a career exploration organization.
This program consisted of a special lecture on the biopharmaceutical industry, a tour of the research institute to see the new drug development process, and an idea contest for developing new drugs and services for patients. It also included a researcher mentoring session where they met directly with pharmaceutical company researchers and answered their questions about career paths and jobs. Through this, participants were able to understand the various processes and researchers’ work related to new drug development, which were difficult to access in the school curriculum.
Copyright © Health Korea News Unauthorized reproduction and redistribution prohibited
Source: www.hkn24.com
